(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-23 View latest technical analysis
10 day averaged volume of Xeris Pharmaceuticals is 1990241
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 7.44 | 7.60 | 7.65 | 7.43 | 0.839 times |
| 22 Thu Jan 2026 | 7.61 | 7.70 | 7.85 | 7.53 | 0.708 times |
| 21 Wed Jan 2026 | 7.62 | 7.58 | 7.71 | 7.47 | 0.735 times |
| 20 Tue Jan 2026 | 7.61 | 7.39 | 7.70 | 7.25 | 0.945 times |
| 16 Fri Jan 2026 | 7.52 | 7.44 | 7.62 | 7.38 | 0.813 times |
| 15 Thu Jan 2026 | 7.41 | 7.56 | 7.60 | 7.36 | 0.902 times |
| 14 Wed Jan 2026 | 7.58 | 7.63 | 7.71 | 7.50 | 0.645 times |
| 13 Tue Jan 2026 | 7.71 | 7.86 | 7.91 | 7.53 | 1.113 times |
| 12 Mon Jan 2026 | 7.87 | 7.87 | 7.97 | 7.69 | 0.795 times |
| 09 Fri Jan 2026 | 7.93 | 8.24 | 8.27 | 7.81 | 1.384 times |
My analysis of stock is bearish for shortterm, and stock might move down till 7.2 or till 6.9. Use a stoploss of 7.51 and if the stock hits stoploss, then it can shoot up till 7.8
Share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Target | 6.47 |
| Downside Target | 6.71 |
| Downside Target | 6.88 |
| Downside Target | 7.20 |
| Upside Target | 7.53 |
| Upside Target | 7.78 |
| Upside Target | 8.22 |
| Upside Target | 8.35 |
| Upside Target | 8.42 |
| Upside Target | 10.03 |
| Upside Target | 10.08 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Intraday Target | 7.18 |
| Downside Intraday Target | 6.91 |
| Upside Intraday Target | 7.78 |
| Upside Intraday Target | 8.11 |
| Upside Intraday Target | 7.51 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 7.44 | 7.39 | 7.85 | 7.25 | 0.756 times |
| 16 Fri Jan 2026 | 7.52 | 7.87 | 7.97 | 7.36 | 0.487 times |
| 09 Fri Jan 2026 | 7.93 | 7.33 | 8.42 | 6.88 | 1.922 times |
| 02 Fri Jan 2026 | 7.35 | 7.30 | 8.22 | 7.20 | 1.496 times |
| 26 Fri Dec 2025 | 7.37 | 7.33 | 7.53 | 7.01 | 0.725 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Fri Jan 2026 | 7.44 | 7.88 | 8.42 | 6.88 | 0.815 times |
| 31 Wed Dec 2025 | 7.85 | 7.08 | 8.22 | 6.47 | 0.845 times |
| 28 Fri Nov 2025 | 7.18 | 9.54 | 10.08 | 6.71 | 1.005 times |
| 31 Fri Oct 2025 | 9.70 | 8.06 | 10.03 | 7.78 | 1.205 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Xeris Pharmaceuticals in short term but the sell signal is initial and weak.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.65 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Xeris Pharmaceuticals in short term but the sell signal is initial and weak.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.65 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.